Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks

Abroad (travel likely)Recruiting

Conditions

Atopic Dermatitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Insight Research Ltd, Quatre Bornes, Mauritius, Mauritius
Contact: Study coordinator (Ashlam DOARIKA) · adoarika@gmail.com · +2304670231
Contact: Principal Investigator (Ashlam DOARIKA)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Metabolic Profiling of Immune Responses in Immune-mediated Diseases

Primary Immunodeficiency · Psoriasis · Atopic Dermatitis

Abroad (travel likely)Recruiting

Bethesda, United States

A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Bryant, United States

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

Moderate-to-Severe Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE3

The Bronx, United States

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · North Little Rock, United States